TIAA CREF INVESTMENT MANAGEMENT LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 146 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$10,248,000
-28.4%
750,772
-46.2%
0.01%
-36.4%
Q4 2018$14,305,000
-59.1%
1,395,609
-33.5%
0.01%0.0%
Q3 2018$34,936,000
+1687.9%
2,098,266
+1596.7%
0.01%
+1000.0%
Q2 2018$1,954,000
-12.2%
123,670
-29.4%
0.00%
-50.0%
Q1 2018$2,226,000
-50.7%
175,290
-55.6%
0.00%
-33.3%
Q4 2017$4,518,000
+122.8%
394,589
+138.3%
0.00%
+200.0%
Q3 2017$2,028,000
+7.1%
165,579
+0.1%
0.00%0.0%
Q2 2017$1,893,000
-36.4%
165,344
+15.6%
0.00%
-50.0%
Q1 2017$2,976,000
-4.6%
143,067
-4.6%
0.00%0.0%
Q4 2016$3,119,000
-32.6%
149,956
+6.2%
0.00%
-33.3%
Q3 2016$4,628,000
+28.8%
141,212
-1.9%
0.00%0.0%
Q2 2016$3,594,000
+109.9%
143,940
+105.9%
0.00%
+200.0%
Q1 2016$1,712,000
-29.8%
69,904
-5.3%
0.00%
-50.0%
Q4 2015$2,438,000
+0.8%
73,8010.0%0.00%0.0%
Q3 2015$2,418,000
-34.8%
73,801
+5.4%
0.00%
-33.3%
Q2 2015$3,709,000
+282.8%
70,023
+108.6%
0.00%
+200.0%
Q1 2015$969,000
+16.7%
33,573
+17.6%
0.00%0.0%
Q4 2014$830,000
+94.8%
28,540
-15.0%
0.00%
Q3 2014$426,000
-31.1%
33,584
+9.0%
0.00%
Q2 2014$618,00030,8040.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Novo Holdings A/S 3,201,183$40,591,0003.96%
Cormorant Asset Management, LP 150,000$1,902,0000.39%
PFM Health Sciences, LP 1,034,030$13,112,0000.30%
Partner Investment Management, L.P. 23,660$300,0000.11%
PointState Capital LP 375,000$4,755,0000.09%
Spark Investment Management LLC 38,400$486,0000.07%
SECTORAL ASSET MANAGEMENT INC 89,300$1,132,0000.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 95,722$1,214,0000.05%
CADIAN CAPITAL MANAGEMENT, LP 120,000$1,522,0000.04%
Nicholas Investment Partners, LP 49,341$626,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders